Floatz logo

Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine

Fallopian Tube Mucinous Neoplasm

Mayo ClinicvaccineEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Fallopian Tube Mucinous Neoplasm cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine is also rated in:

ovarian endometrioid adenocarcinomaDormant
BB
Indicative ·
65 / 100
View asset →
fallopian tube serous adenocarcinomaDormant
BB
Indicative ·
65 / 100
View asset →
primary peritoneal serous adenocarcinomaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →